Yasuhiro Oyama

Kitakyushu, 8020077, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Transvaginal resection of a gastrointestinal stromal tumor of the rectum: a case report.

Transvaginal resection of a gastrointestinal stromal tumor of the rectum: a case report.

Journal: Surgical case reports
Published: May 14, 2024

PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer.

PTPN3 Could Βe a Therapeutic Target of Pancreatic Cancer.

Journal: Anticancer research
Published: April 20, 2022

Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review).

Cancer therapy that targets the Hedgehog signaling pathway considering the cancer microenvironment (Review).

Journal: Oncology reports
Published: January 05, 2022

TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.

TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.

Journal: Anticancer research
Published: May 22, 2021

GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.

GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.

Journal: Oncology reports
Published: August 10, 2020

NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytes.

NFκB and TGFβ contribute to the expression of PTPN3 in activated human lymphocytes.

Journal: Cellular immunology
Published: June 05, 2020

Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy.

Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: December 14, 2019

FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients.

FAM115C could be a novel tumor suppressor associated with prolonged survival in pancreatic cancer patients.

Journal: Journal of Cancer
Published: July 14, 2019

PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor.

PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor.

Journal: Cancer immunology, immunotherapy : CII
Published: February 20, 2019

The Novel Selective Pan-TRK Inhibitor ONO-7579 Exhibits Antitumor Efficacy Against Human Gallbladder Cancer In Vitro.

The Novel Selective Pan-TRK Inhibitor ONO-7579 Exhibits Antitumor Efficacy Against Human Gallbladder Cancer In Vitro.

Journal: Anticancer research
Published: January 19, 2018

Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer.

Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer.

Journal: Anticancer research
Published: September 20, 2017

CD24 Modulates Chemosensitivity of MCF-7 Breast Cancer Cells.

CD24 Modulates Chemosensitivity of MCF-7 Breast Cancer Cells.

Journal: Anticancer research
Published: November 18, 2016
Showing 1-12 of 14

Last Updated: 09/26/2026